Search

A fundamental question in developmental biology is how organ size is controlled. We have previously shown that the area growth rate in the Drosophila eye primordium declines inversely proportionally to the increase in its area. How the observed reduction in the growth rate is achieved is unknown. Here, we explore the dilution of the cytokine Unpaired (Upd) as a possible candidate mechanism. In the developing eye, upd expression is transient, ceasing at the time when the morphogenetic furrow first emerges. We confirm experimentally that the diffusion and stability of the JAK/STAT ligand Upd are sufficient to control eye disc growth via a dilution mechanism. We further show that sequestration of Upd by ectopic expression of an inactive form of the receptor Domeless (Dome) results in a substantially lower growth rate, but the area growth rate still declines inversely proportionally to the area increase. This growth rate-to-area relationship is no longer observed when Upd dilution is prevented by the continuous, ectopic expression of Upd. We conclude that a mechanism based on the dilution of the growth modulator Upd can explain how growth termination is controlled in the eye disc. [ABSTRACT FROM AUTHOR]

Background The Fibroblast Growth Factor (FGF) pathway is driving various aspects of cellular responses in both normal and malignant cells. One interesting characteristic of this pathway is the biphasic nature of the cellular response to some FGF ligands like FGF2. Specifically, it has been shown that phenotypic behaviors controlled by FGF signaling, like migration and growth, reach maximal levels in response to intermediate concentrations, while high levels of FGF2 elicit weak responses. The mechanisms leading to the observed biphasic response remains unexplained. Results A combination of experiments and computational modeling was used to understand the mechanism behind the observed biphasic signaling responses. FGF signaling involves a tertiary surface interaction that we captured with a computational model based on Ordinary Differential Equations (ODEs). It accounts for FGF2 binding to FGF receptors (FGFRs) and heparan sulfate glycosaminoglycans (HSGAGs), followed by receptor-phosphorylation, activation of the FRS2 adapter protein and the Ras-Raf signaling cascade. Quantitative protein assays were used to measure the dynamics of phosphorylated ERK (pERK) in response to a wide range of FGF2 ligand concentrations on a fine-grained time scale for the squamous cell lung cancer cell line H1703. We developed a novel approach combining Particle Swarm Optimization (PSO) and feature-based constraints in the objective function to calibrate the computational model to the experimental data. The model is validated using a series of extracellular and intracellular perturbation experiments. We demonstrate that in silico model predictions are in accordance with the observed in vitro results. Conclusions Using a combined approach of computational modeling and experiments we found that competition between binding of the ligand FGF2 to HSGAG and FGF receptor leads to the biphasic response. At low to intermediate concentrations of FGF2 there are sufficient free FGF receptors available for the FGF2-HSGAG complex to enable the formation of the trimeric signaling unit. At high ligand concentrations the ligand binding sites of the receptor become saturated and the trimeric signaling unit cannot be formed. This insight into the pathway is an important consideration for the pharmacological inhibition of this pathway. [ABSTRACT FROM AUTHOR]

Autocrine/paracrine FGF signaling has been implicated in non-small cell lung cancer (NSCLC) development and progression. In multiple NSCLC cell lines, a switch from FGFR2-IIIb expressed in lung epithelial cells to FGFR1-IIIc and FGFR2-IIIc, results in autocrine response to FGF2 and FGF9 ligands also expressed by these cell lines. FGF2 and FGFR1 expression have also been detected in patient samples and shown to correlate with short survival times. The FGF signaling complex involves a ternary interaction of FGF ligand, receptor, and heparin sulfate glycosaminoglycans (HSGAGs). HSGAGs bind directly to both ligand and receptor, and can serve both to stabilize the receptor-ligand complex and to sequester autocrine/paracrine ligands, increasing local concentrations. A systems approach combining experiment and modeling was used to understand the complex interplay of these components and their implications on cell signaling and behavior. We focused on the signaling behavior of NSCLC cell line NCI-H1703, which predominantly expressed FGFR1. We interrogated pathway dynamics with both FGF2 and FGF9 ligands and found varying Erk1/2 activation kinetics. Using a model encompassing the ternary complex formation in the cellular membrane, ligand-mediated receptor dimerization and phosphorylation, and subsequent kinase cascade to activate Erk1/2, we were able to identify potential mechanisms driving these differences. Additional perturbations of extracellular interactions and intracellular signaling were able to support these hypotheses. These results highlight the role of the extracellular interactions between ligand, receptor, and HSGAGs in controlling downstream behavior. [ABSTRACT FROM AUTHOR]